Comparison 1. Transobturator (TOR) versus retropubic route (RPR).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Subjective cure (short term, ≤ 1 year)	35	5333	Risk Ratio (M‐H, Fixed, 95% CI)	0.97 [0.95, 1.00]
2 Subjective cure and improvement (short term, ≤ 1 year)	10	1651	Risk Ratio (M‐H, Fixed, 95% CI)	0.98 [0.96, 1.00]
3 Subjective cure (medium term, 1 to 5 years)	5	683	Risk Ratio (M‐H, Random, 95% CI)	0.97 [0.87, 1.09]
4 Subjective cure (long term, > 5 years)	4	714	Risk Ratio (M‐H, Random, 95% CI)	0.95 [0.80, 1.12]
5 Subjective cure and improvement (long term, > 5 years)	2	340	Risk Ratio (M‐H, Random, 95% CI)	0.92 [0.67, 1.28]
6 Objective cure (short term, ≤ 1 year)	39	5974	Risk Ratio (M‐H, Fixed, 95% CI)	0.98 [0.96, 1.00]
7 Objective cure and improvement (short term, ≤ 1 year)	10	1478	Risk Ratio (M‐H, Fixed, 95% CI)	0.98 [0.96, 1.01]
8 Objective cure (medium term, 1 to 5 years)	5	596	Risk Ratio (M‐H, Fixed, 95% CI)	1.00 [0.95, 1.06]
9 Objective cure (long term, > 5 years)	3	400	Risk Ratio (M‐H, Fixed, 95% CI)	0.97 [0.90, 1.06]
10 Operative time (minutes)	31	4713	Mean Difference (IV, Random, 95% CI)	‐7.54 [‐9.31, ‐5.77]
11 Operative blood loss (ml)	14	1869	Mean Difference (IV, Random, 95% CI)	‐6.49 [‐12.33, ‐0.65]
12 Length of hospital stay (days)	17	2170	Mean Difference (IV, Random, 95% CI)	‐0.25 [‐0.59, 0.09]
13 Time to return to normal activity level (weeks)	4	626	Mean Difference (IV, Fixed, 95% CI)	‐0.05 [‐0.15, 0.06]
14 Perioperative complications	15	2205	Risk Ratio (M‐H, Fixed, 95% CI)	0.91 [0.73, 1.14]
15 Major vascular or visceral injury	28	4676	Risk Ratio (M‐H, Fixed, 95% CI)	0.33 [0.19, 0.55]
16 Bladder or urethral perforation	39	6173	Risk Ratio (M‐H, Fixed, 95% CI)	0.12 [0.08, 0.20]
17 Voiding dysfunction	37	6200	Risk Ratio (M‐H, Fixed, 95% CI)	0.53 [0.43, 0.65]
18 De novo urgency or urgency incontinence (short term, ≤ 1 year)	31	4923	Risk Ratio (M‐H, Fixed, 95% CI)	0.98 [0.82, 1.17]
19 De novo urgency or urgency incontinence (medium term, 1 to 5 years)	4	481	Risk Ratio (M‐H, Fixed, 95% CI)	0.98 [0.55, 1.73]
20 De novo urgency or urgency incontinence (long term, > 5 years)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
21 Detrusor overactivity	4	566	Risk Ratio (M‐H, Fixed, 95% CI)	1.00 [0.58, 1.73]
22 Vaginal tape erosion	30	4568	Risk Ratio (M‐H, Fixed, 95% CI)	1.03 [0.70, 1.51]
23 Bladder/urethral erosion	4	374	Risk Ratio (M‐H, Fixed, 95% CI)	0.34 [0.01, 8.13]
24 Groin pain	17	3050	Risk Ratio (M‐H, Fixed, 95% CI)	4.45 [2.80, 7.08]
25 Suprapubic pain	4	1105	Risk Ratio (M‐H, Fixed, 95% CI)	0.29 [0.11, 0.78]
26 Repeat incontinence surgery (short term, ≤ 1 year)	8	1221	Risk Ratio (M‐H, Fixed, 95% CI)	1.69 [0.75, 3.80]
27 Repeat incontinence surgery (medium term , 1 to 5 years)	2	355	Risk Ratio (M‐H, Fixed, 95% CI)	21.89 [4.36, 109.77]
28 Repeat incontinence surgery (long term > 5 years)	4	695	Risk Ratio (M‐H, Fixed, 95% CI)	8.79 [3.36, 23.00]